Shots:
- Health2Sync reported the results of their clinical study in Taiwan, demonstrating that integrating Fitbit wearable devices with their Health2Sync patient management platform can help users to control T2DM
- Results: reduction in HbA1C (0.33%); patients who did mod. to high-intensity activity duration of at least 150mins/ week, reduction in HbA1C (0.66%); reduction in fasting BG (10.92 mg/dL), reduction in LDL-C (11.55 mg/dL); reduction of weight up to 2kg; increased frequency in mod. to high-intensity activity to 7.03 times a week among some patients
- The Health2Sync’s platform allows HCPs to seamlessly monitor patients’ information and provide remote consultative advice where necessary
Click here to read full press release/ article | Ref: PRNewswire | Image: Harvey Norman
The post Health2Sync Divulges Benefits of Integrating Fitbit Wearable Devices into Diabetes Care in Taiwan first appeared on PharmaShots.
